1887

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein transforms human lymphocytes and is critical for the pathogenesis of HTLV-1-induced adult T-cell leukaemia. In HTLV-transformed cells, Tax upregulates interleukin (IL)-13, a cytokine with proliferative and anti-apoptotic functions that is linked to leukaemogenesis. Tax-stimulated IL-13 is thought to result in autocrine stimulation of HTLV-infected cells and thus may be relevant to their growth. The causal transactivation of the promoter by Tax is predominantly dependent on a nuclear factor of activated T cells (NFAT)-binding P element. Here, it was shown that the isolated IL-13 Tax-responsive element (IL13TaxRE) was sufficient to mediate IL-13 transactivation by Tax and NFAT1. However, cyclosporin A, a specific NFAT inhibitor, revealed that Tax transactivation of IL13TaxRE or wild-type promoter was independent of NFAT and that NFAT did not contribute to upregulation in HTLV-transformed cells. By contrast, Tax stimulation was repressible by an efficient nuclear factor (NF)-B inhibitor (IkBaDN), indicating the requirement for NF-B. The capacity of NF-B to stimulate IL13TaxRE was demonstrated by a strong response to NF-B in reporter assays and by direct binding of NF-B to IL13TaxRE. Thus, IL13TaxRE in the promoter represents a dually active promoter element responsive to NF-B and NFAT. Together, these results indicate that Tax causes IL-13 upregulation in HTLV-1-infected cells via NF-B.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.2008/003699-0
2008-11-01
2019-11-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/11/2788.html?itemId=/content/journal/jgv/10.1099/vir.0.2008/003699-0&mimeType=html&fmt=ahah

References

  1. Ahlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. K. & Berzofsky, J. A. ( 2002; ). A push–pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L. Proc Natl Acad Sci U S A 99, 13020–13025.[CrossRef]
    [Google Scholar]
  2. Akagi, T., Ono, H., Nyunoya, H. & Shimotohno, K. ( 1997; ). Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 14, 2071–2078.[CrossRef]
    [Google Scholar]
  3. Bargou, R. C., Leng, C., Krappmann, D., Emmerich, F., Mapara, M. Y., Bommert, K., Royer, H. D., Scheidereit, C. & Dorken, B. ( 1996; ). High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed–Sternberg cells. Blood 87, 4340–4347.
    [Google Scholar]
  4. Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A. & other authors ( 1997; ). Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100, 2961–2969.[CrossRef]
    [Google Scholar]
  5. Birnie, G. D. ( 1978; ). Isolation of nuclei from animal cells in culture. Methods Cell Biol 17, 13–26.
    [Google Scholar]
  6. Chung, H. K., Young, H. A., Goon, P. K., Heidecker, G., Princler, G. L., Shimozato, O., Taylor, G. P., Bangham, C. R. & Derse, D. ( 2003; ). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 102, 4130–4136.[CrossRef]
    [Google Scholar]
  7. Crabtree, G. R. & Olson, E. N. ( 2002; ). NFAT signaling: choreographing the social lives of cells. Cell 109 (Suppl.), S67–S79.[CrossRef]
    [Google Scholar]
  8. Deepak, P., Sanjay, K. & Acharya, A. ( 2007; ). IL-13 Rα2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma. J Exp Clin Cancer Res 26, 347–352.
    [Google Scholar]
  9. Dolganov, G., Bort, S., Lovett, M., Burr, J., Schubert, L., Short, D., McGurn, M., Gibson, C. & Lewis, D. B. ( 1996; ). Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87, 3316–3326.
    [Google Scholar]
  10. Farmer, P. K., He, X., Schmitz, M. L., Rubin, J. & Nanes, M. S. ( 2000; ). Inhibitory effect of NF-κB on 1,25-dihydroxyvitamin D3 and retinoid X receptor function. Am J Physiol Endocrinol Metab 279, E213–E220.
    [Google Scholar]
  11. Fraedrich, K., Muller, B. & Grassmann, R. ( 2005; ). The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix. Retrovirology 2, 54 [CrossRef]
    [Google Scholar]
  12. Fujii, M., Chuhjo, T., Minamino, T., Masaaki, N., Miyamoto, K. & Seiki, M. ( 1995; ). Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax. Oncogene 11, 7–14.
    [Google Scholar]
  13. Gauchat, J. F., Schlagenhauf, E., Feng, N. P., Moser, R., Yamage, M., Jeannin, P., Alouani, S., Elson, G., Notarangelo, L. D. & other authors ( 1997; ). A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 27, 971–978.[CrossRef]
    [Google Scholar]
  14. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A. & de The, G. ( 1985; ). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407–410.
    [Google Scholar]
  15. Good, L., Maggirwar, S. B. & Sun, S. C. ( 1996; ). Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO J 15, 3744–3750.
    [Google Scholar]
  16. Good, L., Maggirwar, S. B., Harhaj, E. W. & Sun, S. C. ( 1997; ). Constitutive dephosphorylation and activation of a member of the nuclear factor of activated T cells, NF-AT1, in Tax-expressing and type I human T-cell leukemia virus-infected human T cells. J Biol Chem 272, 1425–1428.[CrossRef]
    [Google Scholar]
  17. Grassmann, R., Aboud, M. & Jeang, K. T. ( 2005; ). Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976–5985.[CrossRef]
    [Google Scholar]
  18. Grossman, W. J., Kimata, J. T., Wong, F. H., Zutter, M., Ley, T. J. & Ratner, L. ( 1995; ). Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 92, 1057–1061.[CrossRef]
    [Google Scholar]
  19. Hall, W. W. & Fujii, M. ( 2005; ). Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 24, 5965–5975.[CrossRef]
    [Google Scholar]
  20. Haller, K., Wu, Y., Derow, E., Schmitt, I., Jeang, K. T. & Grassmann, R. ( 2002; ). Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein. Mol Cell Biol 22, 3327–3338.[CrossRef]
    [Google Scholar]
  21. Hasegawa, H., Sawa, H., Lewis, M. J., Orba, Y., Sheehy, N., Yamamoto, Y., Ichinohe, T., Tsunetsugu-Yokota, Y., Katano, H. & other authors ( 2006; ). Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12, 466–472.[CrossRef]
    [Google Scholar]
  22. Heinemann, S., Biesinger, B., Fleckenstein, B. & Albrecht, J. C. ( 2006; ). NFκB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. J Biol Chem 281, 8565–8572.[CrossRef]
    [Google Scholar]
  23. Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dorken, B., Zenke, M., Stein, H. & Scheidereit, C. ( 2002; ). Nuclear factor κB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196, 605–617.[CrossRef]
    [Google Scholar]
  24. Jeang, K. T. ( 2001; ). Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB. Cytokine Growth Factor Rev 12, 207–217.[CrossRef]
    [Google Scholar]
  25. Jinquan, T., Frydenberg, J., Mukaida, N., Bonde, J., Larsen, C. G., Matsushima, K. & Thestrup-Pedersen, K. ( 1995; ). Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. J Immunol 155, 5359–5368.
    [Google Scholar]
  26. Jost, P. J. & Ruland, J. ( 2007; ). Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109, 2700–2707.
    [Google Scholar]
  27. Kapp, U., Yeh, W. C., Patterson, B., Elia, A. J., Kagi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A. & other authors ( 1999; ). Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed–Sternberg cells. J Exp Med 189, 1939–1946.[CrossRef]
    [Google Scholar]
  28. Krueger, A., Fas, S. C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., Baumann, S., Holtkotte, D., Bosch, V. & other authors ( 2006; ). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood 107, 3933–3939.[CrossRef]
    [Google Scholar]
  29. Li-Weber, M., Giaisi, M., Baumann, S., Palfi, K. & Krammer, P. H. ( 2004; ). NF-κB synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol 34, 1111–1118.[CrossRef]
    [Google Scholar]
  30. Lomo, J., Blomhoff, H. K., Jacobsen, S. E., Krajewski, S., Reed, J. C. & Smeland, E. B. ( 1997; ). Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 89, 4415–4424.
    [Google Scholar]
  31. Macián, F., García-Cózar, F., Im, S. H., Horton, H. F., Byrne, M. C. & Rao, A. ( 2002; ). Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719–731.[CrossRef]
    [Google Scholar]
  32. Manna, S. K. & Aggarwal, B. B. ( 1998; ). IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J Immunol 161, 2863–2872.
    [Google Scholar]
  33. Mathas, S., Lietz, A., Janz, M., Hinz, M., Jundt, F., Scheidereit, C., Bommert, K. & Dorken, B. ( 2003; ). Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis. Blood 102, 1028–1034.[CrossRef]
    [Google Scholar]
  34. Monticelli, S., Solymar, D. C. & Rao, A. ( 2004; ). Role of NFAT proteins in IL13 gene transcription in mast cells. J Biol Chem 279, 36210–36218.[CrossRef]
    [Google Scholar]
  35. Neuveut, C., Low, K. G., Maldarelli, F., Schmitt, I., Majone, F., Grassmann, R. & Jeang, K. T. ( 1998; ). Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol 18, 3620–3632.
    [Google Scholar]
  36. Nicot, C., Mahieux, R., Takemoto, S. & Franchini, G. ( 2000; ). Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96, 275–281.
    [Google Scholar]
  37. Niinuma, A., Higuchi, M., Takahashi, M., Oie, M., Tanaka, Y., Gejyo, F., Tanaka, N., Sugamura, K., Xie, L. & other authors ( 2005; ). Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus. J Virol 79, 11925–11934.[CrossRef]
    [Google Scholar]
  38. Northrop, J. P., Ho, S. N., Chen, L., Thomas, D. J., Timmerman, L. A., Nolan, G. P., Admon, A. & Crabtree, G. R. ( 1994; ). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497–502.[CrossRef]
    [Google Scholar]
  39. Okamoto, K., Fujisawa, J., Reth, M. & Yonehara, S. ( 2006; ). Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-κB. Genes Cells 11, 177–191.[CrossRef]
    [Google Scholar]
  40. Okamura, H., Aramburu, J., García-Rodríguez, C., Viola, J. P., Raghavan, A., Tahiliani, M., Zhang, X., Qin, J., Hogan, P. G. & Rao, A. ( 2000; ). Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell 6, 539–550.[CrossRef]
    [Google Scholar]
  41. Peloponese, J. M., Yeung, M. L. & Jeang, K. T. ( 2006; ). Modulation of nuclear factor-κB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 34, 1–12.[CrossRef]
    [Google Scholar]
  42. Pichler, K., Kattan, T., Gentzsch, J., Kress, A. K., Taylor, G. P., Bangham, C. R. & Grassmann, R. ( 2008; ). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T-cells by the viral Tax oncoprotein. Blood 111, 4741–4751.[CrossRef]
    [Google Scholar]
  43. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. ( 1980; ). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77, 7415–7419.[CrossRef]
    [Google Scholar]
  44. Princler, G. L., Julias, J. G., Hughes, S. H. & Derse, D. ( 2003; ). Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology 317, 136–145.[CrossRef]
    [Google Scholar]
  45. Radonic, A., Thulke, S., Mackay, I. M., Landt, O., Siegert, W. & Nitsche, A. ( 2004; ). Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313, 856–862.[CrossRef]
    [Google Scholar]
  46. Relic, B., Guicheux, J., Mezin, F., Lubberts, E., Togninalli, D., Garcia, I., van den Berg, W. B. & Guerne, P. A. ( 2001; ). IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol 166, 2775–2782.[CrossRef]
    [Google Scholar]
  47. Rivera, I., Harhaj, E. W. & Sun, S. C. ( 1998; ). Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J Biol Chem 273, 22382–22388.[CrossRef]
    [Google Scholar]
  48. Romanchikova, N., Ivanova, V., Scheller, C., Jankevics, E., Jassoy, C. & Serfling, E. ( 2003; ). NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. Immunobiology 208, 361–365.[CrossRef]
    [Google Scholar]
  49. Ruben, S. M., Dillon, P. J., Schreck, R., Henkel, T., Chen, C. H., Maher, M., Baeuerle, P. A. & Rosen, C. A. ( 1991; ). Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251, 1490–1493.[CrossRef]
    [Google Scholar]
  50. Schmitt, I., Rosin, O., Rohwer, P., Gossen, M. & Grassmann, R. ( 1998; ). Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol 72, 633–640.
    [Google Scholar]
  51. Serfling, E., Berberich-Siebelt, F., Chuvpilo, S., Jankevics, E., Klein-Hessling, S., Twardzik, T. & Avots, A. ( 2000; ). The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta 1498, 1–18.[CrossRef]
    [Google Scholar]
  52. Sharma, S., Mamane, Y., Grandvaux, N., Bartlett, J., Petropoulos, L., Lin, R. & Hiscott, J. ( 2000; ). Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. AIDS Res Hum Retroviruses 16, 1613–1622.[CrossRef]
    [Google Scholar]
  53. Sharma, S., Grandvaux, N., Mamane, Y., Genin, P., Azimi, N., Waldmann, T. & Hiscott, J. ( 2002; ). Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J Immunol 169, 3120–3130.[CrossRef]
    [Google Scholar]
  54. Silbermann, K. & Grassmann, R. ( 2007; ). Human T cell leukemia type 1 Tax-induced signals in cell survival, proliferation, and transformation. Signal Transduct 7, 34–52.[CrossRef]
    [Google Scholar]
  55. Skinnider, B. F., Elia, A. J., Gascoyne, R. D., Trumper, L. H., von Bonin, F., Kapp, U., Patterson, B., Snow, B. E. & Mak, T. W. ( 2001; ). Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed–Sternberg cells of Hodgkin lymphoma. Blood 97, 250–255.[CrossRef]
    [Google Scholar]
  56. Skinnider, B. F., Kapp, U. & Mak, T. W. ( 2002; ). The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43, 1203–1210.[CrossRef]
    [Google Scholar]
  57. Smith, M. R. & Greene, W. C. ( 1990; ). Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 4, 1875–1885.[CrossRef]
    [Google Scholar]
  58. Stuver, S. O., Tachibana, N., Okayama, A. & Mueller, N. E. ( 1996; ). Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki. Jpn J Infect Dis 173, 584–591.[CrossRef]
    [Google Scholar]
  59. Sun, S. C. & Yamaoka, S. ( 2005; ). Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene 24, 5952–5964.[CrossRef]
    [Google Scholar]
  60. Taguchi, H. ( 1989; ). Immunologic deficiency in HTLV-I infection. Rinsho Ketsueki 30, 1751–1754 (in Japanese).
    [Google Scholar]
  61. Taylor, G. ( 2007; ). Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J Clin Pathol 60, 1392–1396.
    [Google Scholar]
  62. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E. & Berzofsky, J. A. ( 2000; ). NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1, 515–520.[CrossRef]
    [Google Scholar]
  63. Wäldele, K., Schneider, G., Ruckes, T. & Grassmann, R. ( 2004; ). Interleukin-13 overexpression by Tax transactivation: a potential autocrine stimulus in human T-cell leukemia virus-infected lymphocytes. J Virol 78, 6081–6090.[CrossRef]
    [Google Scholar]
  64. Wäldele, K., Silbermann, K., Schneider, G., Ruckes, T., Cullen, B. R. & Grassmann, R. ( 2006; ). Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 107, 4491–4499.[CrossRef]
    [Google Scholar]
  65. Wright, K., Kolios, G., Westwick, J. & Ward, S. G. ( 1999; ). Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism. J Biol Chem 274, 17193–17201.[CrossRef]
    [Google Scholar]
  66. Yasunaga, J. & Matsuoka, M. ( 2007; ). Leukaemogenic mechanism of human T-cell leukaemia virus type I. Rev Med Virol 17, 301–311.[CrossRef]
    [Google Scholar]
  67. Yoshida, M., Seiki, M., Yamaguchi, K. & Takatsuki, K. ( 1984; ). Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81, 2534–2537.[CrossRef]
    [Google Scholar]
  68. Yu, C. R., Kirken, R. A., Malabarba, M. G., Young, H. A. & Ortaldo, J. R. ( 1998; ). Differential regulation of the Janus kinase–STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 161, 218–227.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.2008/003699-0
Loading
/content/journal/jgv/10.1099/vir.0.2008/003699-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error